Ho WT - Search Results

1

Characterization and functional studies of a FYVE domain-containing phosphatase in C. elegans.

Ma J, Zeng F, Ho WT, Teng L, Li Q, Fu X, Zhao ZJ. Ma J, et al. Among authors: ho wt. J Cell Biochem. 2008 Aug 1;104(5):1843-52. doi: 10.1002/jcb.21752. J Cell Biochem. 2008. PMID: 18393358 Free PMC article.

2

Tea contains potent inhibitors of tyrosine phosphatase PTP1B.

Ma J, Li Z, Xing S, Ho WT, Fu X, Zhao ZJ. Ma J, et al. Among authors: ho wt. Biochem Biophys Res Commun. 2011 Apr 1;407(1):98-102. doi: 10.1016/j.bbrc.2011.02.116. Epub 2011 Feb 28. Biochem Biophys Res Commun. 2011. PMID: 21371422 Free PMC article.

3

Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity.

Chen Y, Guo Y, Han J, Ho WT, Li S, Fu X, Zhao ZJ. Chen Y, et al. Among authors: ho wt. J Hematol Oncol. 2012 Jul 16;5:39. doi: 10.1186/1756-8722-5-39. J Hematol Oncol. 2012. PMID: 22800464 Free PMC article.

4

Loss of tyrosine phosphatase SHP2 activity promotes growth of colorectal carcinoma HCT-116 cells.

Chen X, Fu X, Zhao W, Ho WT, Xing S, Zhao ZJ. Chen X, et al. Among authors: ho wt. Signal Transduct Target Ther. 2020 May 29;5(1):83. doi: 10.1038/s41392-020-0192-0. Signal Transduct Target Ther. 2020. PMID: 32467571 Free PMC article. No abstract available.

5

Identification of a variant form of tyrosine phosphatase LYP.

Wang S, Dong H, Han J, Ho WT, Fu X, Zhao ZJ. Wang S, et al. Among authors: ho wt. BMC Mol Biol. 2010 Nov 2;11:78. doi: 10.1186/1471-2199-11-78. BMC Mol Biol. 2010. PMID: 21044313 Free PMC article.

6

Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth.

Li Z, Xu M, Xing S, Ho WT, Ishii T, Li Q, Fu X, Zhao ZJ. Li Z, et al. Among authors: ho wt. J Biol Chem. 2007 Feb 9;282(6):3428-32. doi: 10.1074/jbc.C600277200. Epub 2006 Dec 18. J Biol Chem. 2007. PMID: 17178722 Free PMC article.

7

Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity.

Li Z, Xing S, Wang S, Ho WT, Zhao ZJ. Li Z, et al. Among authors: ho wt. Exp Hematol. 2007 Nov;35(11):1624-32. doi: 10.1016/j.exphem.2007.07.003. Epub 2007 Aug 30. Exp Hematol. 2007. PMID: 17764811 Free PMC article.

8

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines.

Zhao W, Du Y, Ho WT, Fu X, Zhao ZJ. Zhao W, et al. Among authors: ho wt. Exp Hematol Oncol. 2012 Jun 21;1(1):15. doi: 10.1186/2162-3619-1-15. Exp Hematol Oncol. 2012. PMID: 23210734 Free PMC article.

9

Generation and characterization of a JAK2V617F-containing erythroleukemia cell line.

Zhao W, Zou K, Farasyn T, Ho WT, Zhao ZJ. Zhao W, et al. Among authors: ho wt. PLoS One. 2014 Jul 18;9(7):e99017. doi: 10.1371/journal.pone.0099017. eCollection 2014. PLoS One. 2014. PMID: 25036984 Free PMC article.

10

Quantitative analyses of myelofibrosis by determining hydroxyproline.

Zhao W, Ho WT, Zhao ZJ. Zhao W, et al. Among authors: ho wt. Stem Cell Investig. 2015 Jan 26;2:2. doi: 10.3978/j.issn.2306-9759.2015.01.02. eCollection 2015. Stem Cell Investig. 2015. PMID: 27358870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters